Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: From six to twelve months after volume reduction

Journal of Minimally Invasive Gynecology

Volumn 14, Issue 5, 2007, Pages 616-621

  Funaki, Kaoru ^a   Fukunishi, Hidenobu ^a   Funaki, Tsuyoshi ^b   Kawakami, Chihiro ^c  

^a Shinsuma Hospital   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Focused ultrasound surgery; Magnetic resonance imaging; Nonperfused ratio; Signal intensity; Uterine myoma; Volume reduction ratio

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DEVICE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; JAPAN; MINIMALLY INVASIVE SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; TREATMENT OUTCOME; UTERUS MYOMA;

ADULT; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEIOMYOMATOSIS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MIDDLE AGED; THERMOGRAPHY; TREATMENT OUTCOME; ULTRASONIC THERAPY; UTERINE NEOPLASMS;

EID: 34548399813     PISSN: 15534650     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmig.2007.04.009     Document Type: Article

References (23)

1. Pron G., Bennett J., Common A., et al. The Ontario uterine fibroid embolization trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril 79 (2003) 120-127
2. Spies J.B., Roth A.R., Jha R.C., et al. Leiomyomata treated with uterine artery embolization: factors associated with successful symptom and imaging outcome. Radiology 222 (2002) 45-52
3. deSouza N.M., and Williams A.D. Uterine arterial embolization for leiomyomas: perfusion and volume changes at MR imaging and relation to clinical outcome. Radiology 222 (2002) 367-374
4. Hindley J.T., Law P.A., Hickey M., et al. Clinical outcomes following percutaneous magnetic resonance image guided laser ablation of symptomatic uterine fibroids. Hum Reprod 17 (2002) 2737-2741
5. Sakuhara Y., Shimizu T., Kodama Y., et al. Magnetic resonance-guided percutaneous cryoablation of uterine fibroids: early clinical experiences. Cardiovasc Intervent Radiol 29 (2006) 552-558
6. Bergamini V., Ghezzi F., Cromi A., et al. Laparoscopic radiofrequency thermal ablation: A new approach to symptomatic uterine myomas. Am J Obstet Gynecol 192 (2005) 768-773
7. Funaki K., Fukunishi H., Funaki T., Sawada K., Kaji Y., and Maruo T. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: Relationship between the therapeutic effects and signal intensity of pre-existing T2-weighted MR images. Am J Obstet Gynecol 196 (2007) 184.e1-6
8. Funaki K., and Fukunishi H. The early effects of MRgFUS in treating uterine fibroids. In: Clement G.T., McDannold N.J., and Hynynen K. (Eds). Therapeutic Ultrasound: 5th International Symposium on Therapeutic Ultrasound (2006), AIP, New York, NY 513-517
9. Stewart E.A., Rabinovici J., Tempany C.M., et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 85 (2006) 22-29
10. Hindley J., Gedroyc W.M., Regan L., et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol 183 (2004) 1713-1719
11. Funaki K, Sawada K, Maeda F, et al. Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids. J Obstet Gynaecol Res. (in press).
12. Tempany C.M., Stewart E.A., McDannold N., Quade B.J., Jolesz F.A., and Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 226 (2003) 897-905
13. Smart O.C., Hindley J.T., Regan L., and Gedroyc W.G. Gonadotropin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol 108 (2006) 49-54
14. Nott K.P., Hall L.D., Bows J.R., Hale M., and Patrick M.L. MRI phase mapping of temperature distributions induced in food by microwave heating. Magn Reson Imaging 18 (2000) 69-79
15. Oguchi O., Mori A., Kobayashi Y., Horiuchi A., Nikaido T., and Fujii S. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue. J Obstet Gynaecol 21 (1995) 107-117
16. Yamashita Y., Torashima M., Takahashi M., et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology 189 (1993) 721-725
17. Bell S.W., Kempson R.L., and Hendrickson M.R. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18 (1994) 535-558
18. Christman G.M., and McCarthy J.D. Gene therapy and uterine leiomyomas. Clin Obstet Gynecol 44 (2001) 425-435
19. Ishikawa T., Okai T., Sasaki K., et al. Functional and histological changes in rat femoral arteries by HIFU exposure. Ultrasound Med Biol 29 (2003) 1471-1477
20. Leon-Villapalos J., Kaniorou-Larai M., and Dziewulski P. Full thickness abdominal burn following magnetic resonance guided focused ultrasound therapy. Burns 31 (2005) 1054-1055
21. Furusawa H., Namba K., Thomsen S., et al. Magnetic resonance-guided focused ultrasound surgery of breast cancer: reliability and effectiveness. J Am Coll Surg 203 (2006) 54-63
22. Catane R., Beck A., Inbar Y., et al. MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases-preliminary clinical experience. Ann Oncol 18 (2007) 163-167
23. Rabinovici J., Inbar Y., Eylon S.C., Schiff E., Hananel A., and Freundlich D. Pregnancy and live birth after ultrasound surgery for symptomatic focal adenomyosis: a case report. Hum Reprod 21 (2006) 1255-1259